APA

Tazdait M., Mezquita L., Lahmar J., Ferrara R., Bidault F., Ammari S., Balleyguier C., Planchard D., Gazzah A., Soria J. C., Marabelle A., Besse B. & Caramella C. (20180813). Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria. : European journal of cancer (Oxford, England : 1990).

Chicago

Tazdait M, Mezquita L, Lahmar J, Ferrara R, Bidault F, Ammari S, Balleyguier C, Planchard D, Gazzah A, Soria J C, Marabelle A, Besse B and Caramella C. 20180813. Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria. : European journal of cancer (Oxford, England : 1990).

Harvard

Tazdait M., Mezquita L., Lahmar J., Ferrara R., Bidault F., Ammari S., Balleyguier C., Planchard D., Gazzah A., Soria J. C., Marabelle A., Besse B. and Caramella C. (20180813). Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria. : European journal of cancer (Oxford, England : 1990).

MLA

Tazdait M, Mezquita L, Lahmar J, Ferrara R, Bidault F, Ammari S, Balleyguier C, Planchard D, Gazzah A, Soria J C, Marabelle A, Besse B and Caramella C. Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria. : European journal of cancer (Oxford, England : 1990). 20180813.